Takeda Pharmaceutical Co Ltd - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc (TBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc (TBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc (TBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BiomX Inc (PHGE.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BiomX Inc (PHGE.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made 1 insider transaction in Phathom Pharmaceuticals Inc (PHAT) with a net sale of 3,703,703. Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 36,061 shares made by Molly Henderson , a net sale of 12,715 shares made by Terrie Curran , and a net purchase of 18,500 shares made by Asit Parikh .

In summary, during the past 3 months, insiders sold 20,286 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 20,286 shares. During the past 18 months, 3,765,398 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 41,419 shares were bought by its insiders, resulting in a net sale of 3,723,979 shares.

Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Ovid Therapeutics Inc (OVID). Other recent insider transactions involving Ovid Therapeutics Inc (OVID) include a net purchase of 18,248 shares made by Jeremy M Levin ,

In summary, during the past 3 months, insiders sold 0 shares of Ovid Therapeutics Inc (OVID) in total and bought 18,248 shares, with a net purchase of 18,248 shares. During the past 18 months, 0 shares of Ovid Therapeutics Inc (OVID) were sold and 18,248 shares were bought by its insiders, resulting in a net purchase of 18,248 shares.

Ovid Therapeutics Inc (OVID)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 14,902 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 10,902 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Myovant Sciences Ltd (MYOV). Other recent insider transactions involving Myovant Sciences Ltd (MYOV) include a net sale of 4,051 shares made by Matthew Lang , a net sale of 3,360 shares made by Ferreira Juan Camilo Arjona , and a net purchase of 51,599,200 shares made by Sumitomo Chemical Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,697 shares of Myovant Sciences Ltd (MYOV) were sold and 51,599,200 shares were bought by its insiders, resulting in a net purchase of 51,579,503 shares.

Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 250,000 shares, with a net purchase of 250,000 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Calithera Biosciences Inc (CALA). Other recent insider transactions involving Calithera Biosciences Inc (CALA) include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in BiomX Inc (PHGE). Other recent insider transactions involving BiomX Inc (PHGE) include a net sale of 0 shares made by Assaf Oron , a net purchase of 348,000 shares made by Orbimed Israel Biofund Gp Limited Partnership , and a net sale of 74,955 shares made by Chidozie Ugwumba .

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,869 shares of BiomX Inc (PHGE) were sold and 358,914 shares were bought by its insiders, resulting in a net purchase of 273,045 shares.

BiomX Inc (PHGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 1,200,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 671,932 shares made by Carl L Gordon , and a net purchase of 671,932 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 2,557,866 shares were bought by its insiders, resulting in a net purchase of 2,557,866 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 1,000 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 484,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 126,607 shares made by Samuel C. Blackman , a net sale of 83,857 shares made by Jeremy Bender , and a net sale of 56,236 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 85,781 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 85,781 shares. During the past 18 months, 374,613 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,870,071 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceutical Co Ltd made no insider transaction in HilleVax Inc (HLVX). Other recent insider transactions involving HilleVax Inc (HLVX) include a net sale of 86,866 shares made by Aditya Kohli , a net sale of 48,933 shares made by Astrid Borkowski , and a net sale of 11,597 shares made by Robert Hershberg .

In summary, during the past 3 months, insiders sold 105,972 shares of HilleVax Inc (HLVX) in total and bought 10,100 shares, with a net sale of 95,872 shares. During the past 18 months, 150,972 shares of HilleVax Inc (HLVX) were sold and 10,100 shares were bought by its insiders, resulting in a net sale of 140,872 shares.

HilleVax Inc (HLVX)'s detailed insider trading history can be found in Insider Trading Tracker table.